The thyroid disorder market is witnessing significant trends driven by various factors such as increasing prevalence of thyroid disorders, advancements in diagnostic technologies, and evolving treatment approaches. Thyroid disorders, including hypothyroidism, hyperthyroidism, and thyroid nodules, affect millions of individuals worldwide and require timely diagnosis and management to prevent complications. One notable trend in this market is the rising incidence of thyroid disorders, attributed to factors such as iodine deficiency, autoimmune diseases, genetic predisposition, and environmental factors. As awareness of thyroid health grows and diagnostic capabilities improve, more cases of thyroid disorders are being diagnosed and treated, driving market growth for thyroid disorder management products and services.
Technological advancements play a pivotal role in shaping market trends in the thyroid disorder market. Innovations in diagnostic imaging techniques such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) enable more accurate and detailed visualization of the thyroid gland and surrounding structures. Moreover, molecular diagnostic tests and biomarker assays facilitate the early detection of thyroid cancer and other thyroid-related conditions, improving patient outcomes and guiding treatment decisions. Additionally, telemedicine and remote monitoring technologies enable healthcare providers to remotely assess thyroid function, monitor medication adherence, and adjust treatment regimens as needed, enhancing patient convenience and access to care.
Furthermore, the COVID-19 pandemic has impacted market trends in the thyroid disorder market, influencing healthcare delivery, patient behavior, and treatment approaches. The pandemic has led to disruptions in routine medical care and delayed diagnosis and treatment of thyroid disorders due to resource constraints and safety concerns. However, telehealth services and virtual consultations have emerged as valuable tools for managing thyroid disorders remotely, enabling patients to consult with healthcare providers, refill prescriptions, and monitor their condition from the safety of their homes. Additionally, the pandemic has prompted greater emphasis on preventive healthcare and self-management strategies, driving demand for thyroid health monitoring devices and home-based testing kits.
Another significant trend in the thyroid disorder market is the increasing focus on personalized medicine and targeted therapies. Advances in genomic sequencing and molecular profiling enable healthcare providers to identify specific genetic mutations and molecular markers associated with thyroid cancer and other thyroid disorders. This knowledge allows for more precise diagnosis, prognosis, and treatment selection, optimizing therapeutic outcomes and minimizing side effects. Moreover, targeted therapies such as tyrosine kinase inhibitors and immunotherapy offer promising options for patients with advanced or refractory thyroid cancer, expanding the treatment armamentarium and improving survival rates.
Moreover, demographic shifts and changing lifestyle factors influence market trends in the thyroid disorder market. With aging populations and the increasing prevalence of obesity and autoimmune diseases, there is a growing burden of thyroid disorders worldwide. Additionally, environmental factors such as exposure to radiation, toxins, and pollutants contribute to thyroid dysfunction, further driving the demand for thyroid disorder management products and services. Furthermore, changing dietary patterns and lifestyle habits, including stress, lack of exercise, and poor nutrition, impact thyroid health and increase the risk of thyroid disorders, emphasizing the importance of preventive measures and early intervention.
Regulatory factors also play a significant role in shaping market trends in the thyroid disorder market. Regulatory agencies such as the FDA (Food and Drug Administration) and the European Medicines Agency (EMA) regulate the approval, manufacturing, and marketing of drugs, diagnostic tests, and medical devices used in the diagnosis and treatment of thyroid disorders. Compliance with regulatory standards and guidelines is essential for market entry and commercialization, ensuring product safety, efficacy, and quality. Additionally, reimbursement policies and insurance coverage for thyroid disorder management products and services vary across different regions and healthcare systems, influencing market access and pricing strategies for manufacturers and healthcare providers.
Thyroid Disorder Market Size was valued at USD 2.41 Billion in 2023. The Global Thyroid Disorder industry is projected to grow from USD 2.53 Billion in 2024 to USD 3.55 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.87% during the forecast period (2024 - 2032).
These figures are indeed up-and-coming and ensure that the market has vast scope in the coming future. The disorders that arise due to improper functioning of thyroid glands are referred to as thyroid disorders. This gland is located at the middle level of the lower neck and is responsible for the secretion of the hormone known as thyroid hormone. The primary function of this hormone is to regulate the activities related to metabolism in the body. If an individual suffers from thyroid disorders, it leads to an increased or decreased level of hormones responsible for metabolism in the body.
Such elevation or decrease in thyroid disorder symptoms causes hypothyroidism, hyperthyroidism, and many more. The main elements driving the thyroid disorder market are the fact that people are getting more awareness about the thyroid disorder causes and the medical health policies, making them more aware of their health. But factors that restrict or push back the market are the pensive procedures involved are relatively high and also have known to cause side effects.
COVID-19 analysis
The entire world has witnessed an unforgettable time with the COVID 19 pandemic attack. Lives for everyone have taken a turn. Businesses have been affected the most, and getting back to normal would take some time for sure. Even after utilizing resources and human resources, each company would require mentorship and guidance to ensure that they are on the correct track and cope with whatever they have lost in a short period.
The reports prepared provide insights about all thin depth analyses carried out by the experts over the last few months. The reports have a particular focus on the effect that the pandemic has bought on the companies. This is one of those cost-effective measures that have expertise attached to them yet are budget-friendly. They also provide the current situation of the market in various countries.
Market Dynamics
Thyroid-related disorders have been increasing each year. Thyroid disorder causes include bad eating habits or other related factors. According to recent research, more than 12% of the total population in the united states is suffering thyroid-related disorder, which is, in fact, a considerable figure. It's just in the states, but other developed and developing countries like India, UK, and many more have also seen a similar rise in the figures. Hypothyroidism is prevalent in a developed region like the United Kingdom, where around 27.7% of the total population suffers from the same. Type-increasing figures have given a boost to the thyroid disorder market size in the last few years. It has also been studied that thyroid-related disorders are even more common than diseases like cancer.
Regulatory implications
Marketing, production, and the distribution of the thyroid disorder market are regulated by FDA or food and drug administration. In Europe, it is controlled by EMA or European Medicines Agency. In a recent study, it has been revealed that FDA and EMA both have almost the same criteria for regulations of the products and services in the market. These organizations are being planned to make sure that drugs can be made available to people at many affordable rates. These keep a check of how the service and or products are being marketed and manufactured. The bodies that regulate the fact that the users with thyroid disorder symptoms get everything at affordable prices are not compromises on the quality have proved to bring sustainability and stability in the thyroid disorder market.
Various segments in which the market has been divided are
By type, the thyroid disorder market is sub-divided into:
• Hypothyroidism
• Hyperthyroidism
There is three subdivision in the thyroid gland disorders treatment market :
• Medications
• Surgery
• Radioactive iodine therapy
There are a further three sub-divisions based on the route of administration. These are:
• Intravenous
• Oral
• Other
These are further subdivided into three subtypes. These are:
• Clinics
• Hospitals
• Others
The market is divided into the Americas, the Asia Pacific, the middle east, Africa, and Europe based in the regions.
The Americas dominate the thyroid disorder market size, mainly because of the high population suffering from one of the other thyroid-related disorders. According to a survey conducted in the year 2016, almost 13 million people suffer from these disorders. There has been advancement in medicines and thyroid disorder treatment procedures for thyroid-related conditions as well. Moreover, awareness among the population has to lead to growth and the market too.
The region that bags the second place is that of Europe. An increase in the number of pharmaceutical companies that export their products outside Europe has contributed to the market's growth to a great extent. Research and the development of medicines for thyroid-related disorders have been a main task foremost in Europe. Not only this, but there has been a sharp increase in the investments made in pharmaceutical logistics, which is also a critical factor in the growth of the market in Europe as per the latest thyroid disorder case study.
The fastest-growing thyroid disorder market share is that of Asia Pacific, which can be considered the destinations outsourced for clinical trials, testing, and manufacturing of drugs. Sideways, third-party pharmaceutical companies are also looking to expand their business in developing countries like India, Singapore, China.
Competitive landscape
Here is a list of the key contenders of the thyroid disorder market according to the latest thyroid disorder case study. Pfizer Inc (US) can be considered the top-notch company that leads the thyroid disorder market.
The companies that also have a significant role in the market are:
As can be seen, most of the key players are from the united states. Reason being that it dominates the thyroid disorder treatment market for the highest population suffering from such diseases. The strategies that all of them have been following to reach today include product development, expansion, and innovation.
Recent developments
Recent development in the thyroid disorder market are
• In November 2015, a program that focuses on managing the daily routine of those having the life-long condition of hypothyroidism was launched by Abbie under Good Morning Hypothyroidism (GMH).
• In October 2016, ThyroTest was introduced by Abbott acquired Alere Inc., a service provider organization and a diagnostic device manufacturer introduced in the market, which is a test to detect hypothyroidism.
• In March 2018, an orally available tyrosine kinase inhibitor was discovered by Eisai.
• Also, in the same month, it was announced by Eisai Co Ltd and Merck about their strategic collar radiation. They are popularly called MSD after the collaboration.
• The commercialization of LENVIMA was also done in the year 2018.
Report overview
A market that is all set to reach a CAGR that equals a great figure is the global thyroid disorder market. While the population is experiencing an increased rate of thyroid disorders, the growth that the thyroid disorder market share has seen and is expected to see is tremendous. Rising awareness about the illness is another factor contributing to being the growth of the market.
On the other hand, in developed or underdeveloped countries, the market's development is sluggish due to the availability of inadequate health facilities, high cost of thyroid gland disorders treatment market, and lack of awareness. The trend and growth of the market are increasing slowly but would take a little time.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)